BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21601255)

  • 1. Postprostatectomy established stress urinary incontinence treated with duloxetine.
    Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
    Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
    Schlenker B; Gratzke C; Reich O; Schorsch I; Seitz M; Stief CG
    Eur Urol; 2006 Jun; 49(6):1075-8. PubMed ID: 16481094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is HCl duloxetine effective in the management of urinary stress incontinence after radical prostatectomy?
    Zahariou A; Papaioannou P; Kalogirou G
    Urol Int; 2006; 77(1):9-12. PubMed ID: 16825808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
    Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
    Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of duloxetine for stress incontinence after prostatectomy.
    Hotston MR; Hurley K; Patel S; Persad R
    BJU Int; 2006 Oct; 98(4):916-7. PubMed ID: 16978296
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
    Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
    Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.
    Kotecha P; Sahai A; Malde S
    Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conservative treatment of male stress incontinence].
    Buse S; Reitz A; Haferkamp A; Hohenfellner M
    Urologe A; 2007 Mar; 46(3):240-3. PubMed ID: 17294152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place of duloxetine in the treatment of stress urinary incontinence].
    Rouprêt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
    Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
    Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
    Puyol M; Collado A
    Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.